Christoph Miethke and Aesculap found joint venture
Christoph Miethke announced together with Aesculap AG, a subsidiary of B. Braun Melsungen AG, the formation of the joint venture B. Braun Miethke GmbH & Co. KG.
The newly established B. Braun Miethke GmbH & Co. KG, based in Potsdam, is devoted to developing innovative implants for targeted drug delivery. Under the direction of Brandon Loudermilk, the company is expected to bring its first product in this field to the market within the next years.
In contrast to conventional, oral drug administration, where the drug passes through the entire body, implants for targeted drug delivery transport pharmaceuticals directly to the targeted location in the patient’s body. This allows for a significant dose reduction and therefore reduces undesirable side effects for the patients.
25th Anniversary Miethke, July 8th, 2017 in Potsdam, Germany
Meet, celebrate, be together.
We spent the day together on a journey through 25 years of the company’s history, we played soccer and someone definitely won. Our team? …certainly not Miethke, that we would have remembered. Those who did not play soccer, were ambitiously playing other games. We had theater at its best and many many conversations.
Everyone together. This was our wish...and, this was our experience.
A special day of gathering, with all of the guests that came by that day. Thank you for spending this occasion with us and making it to a very special experience.